Home Newsletters Cell Therapy News Chimeric Antigen Receptor (CAR) T-cell Treatment for Mantle Cell Lymphoma (MCL)

Chimeric Antigen Receptor (CAR) T-cell Treatment for Mantle Cell Lymphoma (MCL)

0
Investigators provided an overview for the available management strategies for relapsed mantle cell lymphoma (MCL) and examines the role of CAR T cell in the current and future treatment of MCL.
[Therapeutic Advances in Hematology]

Sorry, but the selected Zotpress account can't be found.

Full Article
Exit mobile version